Leading the way in stroke recovery
Dr. Ed Wong, Kandu Stroke Survivor
Kandu is revolutionizing stroke recovery. By combining brain activated therapy with personalized telehealth services, we deliver a first-of-its-kind solution that empowers stroke survivors and transforms outpatient stroke care.
Our Mission
Kandu empowers people affected by stroke through personalized and breakthrough technologies, setting a new standard of care for stroke recovery that is accessible to patients at home.
Support Grounded in Clinical Research and Survivor Experience
Neurolutions
Neurolutions is dedicated to transforming the lives of patients suffering from neurological conditions. Our IpsiHand® device is a breakthrough brain-computer interface that helps patients regain hand function after stroke or other brain injuries. The IpsiHand® device has been clinically validated and has received FDA clearance for use in the United States.
Kandu Health
Kandu Health provides outpatient Principal Illness Navigation and recovery support to stroke survivors and their care partners. Our patient-centered approach aims to improve quality of life and reduce the likelihood of rehospitalization. Kandu provides healthcare systems and payers with assurance that their patients are provided the recovery resources they need.
Better Together
Patients recover best with a holistic approach. That’s why we’ve combined IpsiHand’s advanced BCI technology with Kandu’s clinical services and stroke survivor communities. This merger creates a more comprehensive recovery experience, where personalized care and cutting-edge technology work together to maximize outcomes. By bringing technology and clinical expertise to patients recovering at home, we offer a more effective path to recovery– helping stroke survivors regain mobility, independence, and a better quality of life.
Leo Petrossian
Chief Executive Officer // Director
Dr. Leo Petrossian is the Chief Executive Officer of Kandu Inc., a neurotechnology company formed from the merger of Neurolutions and Kandu Health. He is a seasoned healthcare executive and entrepreneur with deep expertise in bringing transformative medical devices from early development to commercialization. Under his leadership, Neurolutions pioneered the IpsiHand®, the first FDA-cleared brain–computer interface for stroke rehabilitation. Dr. Petrossian is passionate about advancing technologies that expand access, improve outcomes, and reshape standards of care in neurology and beyond.
Education
Dr. Petrossian earned his MBA from the UCLA Anderson School of Management in 2014 and earned his Ph.D. & MS in Biomolecular Nanotechnology & Solid-State Device Physics as an NSF IGERT fellow at Arizona State University in 2007. He also holds a double B.S. in Electrical Engineering & Biomedical Engineering from California State University, Long Beach.
Nabeel Ahmed
Chief Financial Officer
Nabeel is the Chief Financial Officer of Kandu, Inc. Prior to joining Kandu, he was the Chief Financial Officer of Outset Medical, Inc., a medical dialysis technology company. Prior to Outset Medical, Nabeel held a variety of finance leadership roles, including as Vice President, Finance at 8×8, Inc., a communications platform provider, and at Vocera Communications, Inc., a provider of clinical workflow solutions. Previously, he held various leadership positions in accounting and finance, including as CFO of Wanderful Media as well as CFO of MarketTools, Inc. Earlier in his career, he served in positions of increasing responsibility at Ernst & Young, LLP and at eBay, Inc. Nabeel holds a Bachelor of Commerce degree from Laurentian University, and an M.B.A., from the Wharton School, University of Pennsylvania.
Kirsten Carroll
General Manager // Chief Marketing Officer
Kirsten has over 20 years of experience in stroke with various leadership roles at Boston Scientific, Stryker, and Imperative Care. She was the Founder and Chief Executive Officer of Kandu Health and became the Chief Marketing Officer and General Manager of Clinical Services at the conclusion of the merger with Neurolutions in March 2025. Kirsten holds several patents in the fields of stroke treatment and detection, and she is the author of several peer-reviewed papers in the field of stroke and access to care.
Andy Schultz
Chief Commercial Officer
Andy Schultz is the Chief Commercial Officer of Kandu, Inc. Previously, Andy was the SVP of Revenue and Operations at Candid, a disruptor in the orthodontic clear aligner space. Prior to Candid, Andy was the Vice President Customer Experience and Planning at Scotts Miracle-Gro. Over 13 years there he held various leadership roles in sales, operations, strategy and supply chain. Prior to that time, Andy was a First Officer for Northwest Airlink. He served 8 years in the US Navy aboard the USS Enterprise and as a part of the Blue Angels Flight Demonstration Squadron. Andy graduated from Embry-Riddle Aeronautical University.
Javad Seyedzadeh
Chief Operating Officer
With over 35-years of experience in healthcare leadership, Javad has extensive experience in overall operations (product development, manufacturing and QA/RA) on a global scale, including North America, Europe, Latin America, and Asia. Javad has held executive roles at Gambro, Toshiba Medical Systems, Bayer Healthcare, Siemens Healthcare, and NovaSignal and Nile.ai. Javad’s business-oriented approach extends to product development and operational excellence. He has been instrumental in streamlining processes, reducing product costs, and implementing efficient organizational designs. His leadership has been crucial in driving product development strategies that align with regulatory compliance and market needs.
Seth Wilk
Chief Innovation Officer
Seth Wilk is the Chief Innovation Officer at Kandu, Inc., with 20 years of experience in research, development, and intellectual property. He has authored over 100 publications and patents, secured more than $50M in federal grant funding, and led multiple clinical studies and trials. Dr. Wilk earned his PhD and MS in Biomolecular Nanotechnology as an NSF IGERT Fellow at Arizona State University in 2005, and holds a BS in Electrical Engineering from The College of New Jersey.
Nancey Trevanian Tsai, MD
Medical Director, Kandu Medical Services
Nancey Trevanian Tsai, MD is a Diplomate of the American Board of Physical Medicine and Rehabilitation. She is the Associate Program Director of the HCA Trident Healthcare PM&R Residency, Eta Kappa Nu, Senior Member, and Chair of the South Carolina section of the IEEE. She has served as a past Chair of the American Council on Exercise and past Chair of the South Carolina Medical Association Young Physicians Section. She has a patent for the Blink Reflexometer in Australia and Japan, and the United States. She is a mother, a musician, and a former Olympic athlete and coach.
Eric Leuthardt, MD
Neurolutions Founder // Chief Scientific Officer
Eric C. Leuthardt, M.D. is a highly regarded neurosurgeon and professor at Washington University in St. Louis. He holds positions in several departments, including Neurological Surgery, Neuroscience, Biomedical Engineering, Mechanical Engineering, and Material Sciences, and serves as the Chief of the Division of Neurotechnology. Leuthardt is known for his innovative research in the field of neuroprosthetics, neurotechnologies, advanced brain imaging, and neurosurgical devices. His work has earned him recognition as a pioneer in applied neuroscience and he has over 1800 patents filed with the US Patent and Trademark Office for various medical devices and brain-computer interface technologies. In addition to his academic and research achievements, he is also a successful entrepreneur, having founded eight startup companies.
Tudor Jovin, MD
Chief Medical Officer
Internationally acclaimed neurologist and researcher, Tudor G. Jovin, MD, is based at Cooper University Hospital in Camden, New Jersey, and presides as the Chief and Chairman of Cooper Neurological Institute. Dr. Jovin is an expert in the interventional and non-interventional treatment for the entire spectrum of stroke and cerebrovascular disorders. He has served as principal investigator for several international clinical studies, including REVASCAT, and has published more than 300 articles in peer-reviewed journals or book chapters.
Fred Khosravi
Chairman of the Board
Fred Khosravi is a Silicon Valley medical device entrepreneur with over 30 years of experience in medical technology. He has co-founded Incept LLC and serves as its managing director, focusing on technology innovation and entrepreneurship in the life-sciences field. Fred is credited as an inventor or co-inventor on over 200 patents and patent applications globally.
Science
Neurolutions
Kandu Health
Publications
2022 Brain Communications Publication
Theta–gamma coupling as a cortical biomarker of brain–computer interface
2022 Brain-Computer Interfaces Publication
Motor Network Reorganization Induced in Chronic Stroke Patients with interface
2024 Brain-Computer Interface Publication
BCI Therapy Induces Broad Upper Extremity Motor Rehabilitation in Chronic Stroke
FDA Cleared
IpsiHand is FDA Cleared
Neurolutions Awarded
California Life Science Medical Device of the year
Breakthrough Research
Newly published studies show motor recovery in chronic stroke patients.
FDA Granted
IpsiHand as a “ Breakthrough Medical Technology“
100 Patient Outcomes
Demonstrated over a 50% reduction of inpatient readmissions compared to published ranges.